Key Inclusion Criteria:~* Age 50-89 (inclusive) at screening~* Diagnosed as having Mild Cognitive Impairment
(MCI) due to Alzheimer's disease (AD) or Mild probable AD according to workgroups of the Diagnostic Guidelines
of the National Institute on Aging and Alzheimer's Association (NIA-AA)~* Mini-Mental State Examination (MMSE)
score 20-30 inclusive at screening~* Montreal Cognitive Assessment score (MoCA) < 26 at screening~* Clinical
Dementia Rating global score 0.5 or 1 with memory score of > 0.5 at screening~* Positive CSF AD biomarker
signature~* A brain MRI scan within 6 months of screening consistent with a diagnosis of Alzheimer's disease~*
Participants must have a study partner who has frequent interaction with them (approximately >3-4 times per
week), will be present for all clinic visits, and can assist in compliance with study procedures.~Key
